{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:31:56Z","timestamp":1785551516397,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115249","type":"journal-article","created":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T08:51:15Z","timestamp":1753001475000},"page":"115249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cyclobenzaprine HCl ameliorates OVA-induced asthma through modulating the TLR4\/MyD88\/NF-\u03baB and PI3K\/AKT\/mTOR signaling pathways"],"prefix":"10.1016","volume":"163","author":[{"given":"Haoyu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115249_bb0005","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.3390\/cells11172764","article-title":"Current understanding of asthma pathogenesis and biomarkers","volume":"11","author":"Habib","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.115249_bb0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/all.13966","article-title":"Different endotypes and phenotypes drive the heterogeneity in severe asthma","volume":"75","author":"McDowell","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2025.115249_bb0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115249_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00011-018-1191-2","article-title":"A review of inflammatory mechanism in airway diseases","volume":"68","author":"Aghasafari","year":"2019","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2025.115249_bb0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.anai.2019.08.462","article-title":"Evaluating direct costs and productivity losses of patients with asthma receiving GINA 4\/5 therapy in the United States","volume":"123","author":"Settipane","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"2022","key":"10.1016\/j.intimp.2025.115249_bb0030","first-page":"17","article-title":"Executive summary and rationale for key changes","volume":"205","author":"Reddel","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115249_bb0035","doi-asserted-by":"crossref","first-page":"1800703","DOI":"10.1183\/13993003.00703-2018","article-title":"Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature","volume":"52","author":"Volmer","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2025.115249_bb0040","doi-asserted-by":"crossref","first-page":"838","DOI":"10.21037\/atm-22-3219","article-title":"Cellular sources of airway smooth muscle cells in asthmatic airway remodeling and their clinical relevance: a narrative review","volume":"10","author":"Li","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.intimp.2025.115249_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110340","article-title":"circ_CSNK1E modulates airway smooth muscle cells proliferation and migration via miR-34a-5p\/VAMP2 axis in asthma","volume":"95","author":"Ding","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2025.115249_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13578-020-00470-8","article-title":"Dandelion extract relaxes mouse airway smooth muscle by blocking VDLCC and NSCC channels","volume":"10","author":"Zhao","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.intimp.2025.115249_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/1440-1681.13030","article-title":"Inflammatory cytokines tumour necrosis factor-\u03b1 and interleukin-8 enhance airway smooth muscle contraction by increasing L-type Ca2+ channel expression","volume":"46","author":"Ding","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.intimp.2025.115249_bb0060","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The cytokines of asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115249_bb0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.anl.2011.01.011","article-title":"Pathogenesis of airway inflammation in bronchial asthma","volume":"38","author":"Nakagome","year":"2011","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.intimp.2025.115249_bb0070","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/cells8040342","article-title":"Extracellular matrix component remodeling in respiratory diseases: what has been found in clinical and experimental studies?","volume":"8","author":"Ito","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.115249_bb0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201810-1855OC","article-title":"Defective Fibrillar collagen organization by fibroblasts contributes to airway remodeling in asthma","volume":"200","author":"Mosta\u00e7o-Guidolin","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115249_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/747584","article-title":"The role of the extracellular matrix components in cutaneous wound healing","volume":"2014","author":"Olczyk","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2025.115249_bb0085","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1513\/pats.200907-067DP","article-title":"The role of the epithelium in airway remodeling in asthma","volume":"6","author":"Davies","year":"2009","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.intimp.2025.115249_bb0090","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.clinthera.2004.09.008","article-title":"Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone","volume":"26","author":"Toth","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.intimp.2025.115249_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005281","article-title":"Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice","volume":"11","author":"Cunha-J\u00fanior","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.intimp.2025.115249_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106009","article-title":"Energy metabolism as a target for cyclobenzaprine: a drug candidate against visceral Leishmaniasis","volume":"127","author":"Lima","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.intimp.2025.115249_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.20076","article-title":"Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis","volume":"51","author":"Tofferi","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2025.115249_bb0110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/jpet.121.000998","article-title":"The skeletal muscle relaxer cyclobenzaprine is a potent non-competitive antagonist of histamine H1 receptors","volume":"380","author":"Singh","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2025.115249_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-2999(02)02735-8","article-title":"Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT(2) receptors","volume":"458","author":"Honda","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115249_bb0120","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-023-01892-5","article-title":"Duloxetine HCl alleviates asthma symptoms by regulating PI3K\/AKT\/mTOR and nrf2\/HO-1 signaling pathways","author":"Peng","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2025.115249_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1540\/jsmr.49.112","article-title":"Chloride channel blockers promote relaxation of TEA-induced contraction in airway smooth muscle","volume":"49","author":"Yim","year":"2013","journal-title":"J. Smooth Muscle Res."},{"key":"10.1016\/j.intimp.2025.115249_bb0130","first-page":"L803","article-title":"Androgen receptor activation alleviates airway hyperresponsiveness, inflammation, and remodeling in a murine model of asthma","volume":"320","author":"Kalidhindi","year":"2021","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.intimp.2025.115249_bb0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13287-020-02072-0","article-title":"Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice","volume":"12","author":"Dong","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.intimp.2025.115249_bb0140","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2017.05.053","article-title":"Inflammatory mediators mediate airway smooth muscle contraction through a G protein-coupled receptor-transmembrane protein 16A-voltage-dependent Ca2+ channel axis and contribute to bronchial hyperresponsiveness in asthma","volume":"141","author":"Wang","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2025.115249_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1513\/pats.200704-050VS","article-title":"Regulation of airway smooth muscle cell contractility by Ca2+ signaling and sensitivity","volume":"5","author":"Sanderson","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.intimp.2025.115249_bb0150","article-title":"Neuro-immune regulation in inflammation and airway remodeling of allergic asthma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115249_bb0155","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.immuni.2015.09.012","article-title":"The intestinal microbiota contributes to the ability of helminths to modulate allergic inflammation","volume":"43","author":"Zaiss","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115249_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.coph.2004.01.011","article-title":"Airway mucus hypersecretion in asthma: an undervalued pathology?","volume":"4","author":"Rogers","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115249_bb0165","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/all.16242","article-title":"Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma","volume":"79","author":"Rupani","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2025.115249_bb0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/rccm.200809-1505OC","article-title":"Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma","volume":"180","author":"McGee","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115249_bb0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12931-023-02550-y","article-title":"MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4\/MyD88\/NF-\u03baB pathway","volume":"24","author":"Liu","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2025.115249_bb0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10753-022-01715-z","article-title":"PCSK9 promotes endothelial dysfunction during Sepsis via the TLR4\/MyD88\/NF-\u03baB and NLRP3 pathways","volume":"46","author":"Huang","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2025.115249_bb0185","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10753-020-01363-1","article-title":"Silencing TLR4\/MyD88\/NF-\u03baB signaling pathway alleviated inflammation of corneal epithelial cells infected by ISE","volume":"44","author":"Wu","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2025.115249_bb0190","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2174\/1389450117666161013115225","article-title":"Phosphoinositide-3-kinases as the novel therapeutic targets for the inflammatory diseases: current and future perspectives","volume":"18","author":"Vyas","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.intimp.2025.115249_bb0195","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S2213-2600(23)00230-8","article-title":"2023 GINA report for asthma","volume":"11","author":"Venkatesan","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.intimp.2025.115249_bb0200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3810\/pgm.2010.07.2182","article-title":"Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: a pooled analysis","volume":"122","author":"Weil","year":"2010","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.intimp.2025.115249_bb0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2465","article-title":"The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines","volume":"7","author":"Thurmond","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2025.115249_bb0210","doi-asserted-by":"crossref","first-page":"32877","DOI":"10.1074\/jbc.R110.215491","article-title":"Ion channels in asthma","volume":"286","author":"Valverde","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.115249_bb0215","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2019.04.043","article-title":"Molecular basis for ligand modulation of a mammalian voltage-gated Ca2+ channel","volume":"177","author":"Zhao","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115249_bb0220","first-page":"118","article-title":"Understanding the immunology of asthma: pathophysiology, biomarkers, and treatments for asthma endotypes","volume":"36","author":"Gans","year":"2020","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.intimp.2025.115249_bb0225","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.20032014","article-title":"Interferon gamma enhances both in vitro and in vivo priming of CD4+ T cells for IL-4 production","volume":"199","author":"Bocek","year":"2004","journal-title":"J. Exp. Med."},{"issue":"Suppl. 61","key":"10.1016\/j.intimp.2025.115249_bb0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1034\/j.1398-9995.2000.00511.x","article-title":"Th1\/Th2 lymphocyte polarization in asthma","volume":"55","author":"Mazzarella","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2025.115249_bb0235","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/cells13050384","article-title":"Eosinophilic asthma: pathophysiology and therapeutic horizons","volume":"13","author":"Hussain","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.115249_bb0240","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fphys.2015.00312","article-title":"Molecular regulation of toll-like receptors in asthma and COPD","volume":"6","author":"Zuo","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2025.115249_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155410","article-title":"Protopine ameliorates OVA-induced asthma through modulatingTLR4\/MyD88\/NF-\u03baB pathway and NLRP3 inflammasome-mediated pyroptosis","volume":"126","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.115249_bb0250","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.neuroscience.2010.03.067","article-title":"Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity","volume":"168","author":"Hutchinson","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2025.115249_bb0255","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2025.115249_bb0260","first-page":"437","article-title":"Developing PI3K inhibitors for respiratory diseases","volume":"436","author":"Fagone","year":"2022","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.intimp.2025.115249_bb0265","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115249_bb0270","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s13273-021-00155-4","article-title":"Down-regulation of PTTG1 suppresses PDGF-BB-induced proliferation, migration and extracellular matrix production of airway smooth muscle cells (ASMCs) by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"17","author":"Cheng","year":"2021","journal-title":"Mol. Cell. Toxicol."},{"key":"10.1016\/j.intimp.2025.115249_bb0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/01902148.2020.1740356","article-title":"IL-27 alleviates airway remodeling in a mouse model of asthma via PI3K\/Akt pathway","volume":"46","author":"Li","year":"2020","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.intimp.2025.115249_bb0280","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s10753-021-01466-3","article-title":"PI3K\/AKT\/mTOR and TLR4\/MyD88\/NF-\u03baB signaling inhibitors attenuate pathological mechanisms of allergic asthma","volume":"44","author":"Ma","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2025.115249_bb0285","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jimmun\/vkae037","article-title":"MyD88 determines T cell fate through BCAP-PI3K signaling","volume":"214","author":"Bayer","year":"2025","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115249_bb0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/nyas.12059","article-title":"Role of PI3K\/Akt and mTOR complexes in Th17 cell differentiation","volume":"1280","author":"Nagai","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925012391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925012391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:08:54Z","timestamp":1757912934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925012391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":58,"alternative-id":["S1567576925012391"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115249","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclobenzaprine HCl ameliorates OVA-induced asthma through modulating the TLR4\/MyD88\/NF-\u03baB and PI3K\/AKT\/mTOR signaling pathways","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115249"}}